Detalles de la búsqueda
1.
Characterization of (2R, 3S)-2-([[4-(2-butynyloxy)phenyl]sulfonyl]amino)-N,3-dihydroxybutanamide, a potent and selective inhibitor of TNF-alpha converting enzyme.
Int Immunopharmacol
; 4(14): 1845-57, 2004 Dec 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-15531300
2.
Identification of potent and selective MMP-13 inhibitors.
Bioorg Med Chem Lett
; 15(18): 4105-9, 2005 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-16005220
3.
Identification and characterization of 4-[[4-(2-butynyloxy)phenyl]sulfonyl]-N-hydroxy-2,2-dimethyl-(3S)thiomorpholinecarboxamide (TMI-1), a novel dual tumor necrosis factor-alpha-converting enzyme/matrix metalloprotease inhibitor for the treatment of rheumatoid arthritis.
J Pharmacol Exp Ther
; 309(1): 348-55, 2004 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-14718605
Resultados
1 -
3
de 3
1
Próxima >
>>